Clinical Trials · NCT06207877
A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body Weight
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 62
- Start date
- Feb 2024
- Locations
- 1 site, Germany
- Primary endpoint
- Relative change in energy intake during ad libitum lunch, evening meal and snackbox